To determine the generality of our findings for different types of cells, we tested the effects of siRNAs targeting CstF-64, CPSF73 or CFIm25 on the migration of triple negative breast cancer cells (Additional file 1: Figure S3). This evidence concerns the gene NUDT21 and triple-negative breast carcinoma.